Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.

Click Here

Executive Interviews

Investing For Life: Q&A With Sofinnova Chairman Antoine Papiernik

Paris-based Sofinnova Partners, a life science venture capital firm, has been an early investor in companies such Genentech and Biogen, and now has over $2.5 billion invested in sciences, primarily in healthcare and sustainability. Antoine Papiernik, Sofinnova chairman and managing partner, speaks with Global Finance about the state of life sciences today and in future.

News

License To Pollute

The newest carbon-credit initiative out of COP27 doesn’t seem to answer the old critiques.

Economics, Policy & Regulation

Central Banker Report Cards 2022

After years of easy money, central banks are tightening up—some more quickly than others. Global Finance grades their performance in the face of the past year’s rising inflation.

Economics, Policy & Regulation

Rising Recession Risk

Central bank rate-hiking may bring on a recession, unemployment and debt defaults. Some say that’s just the price of suppressing inflation.
arrow-chevron-right-redarrow-chevron-rightbutton-arrow-left-greybutton-arrow-left-red-400button-arrow-left-red-500button-arrow-left-red-600button-arrow-left-whitebutton-arrow-right-greybutton-arrow-right-red-400button-arrow-right-red-500button-arrow-right-red-600button-arrow-right-whitecaret-downcaret-rightclosecloseemailfacebook-square-holdfacebookhamburger-newhamburgerinstagramlinkedin-square-1linkedinpauseplaysearch-outlinesearchsubscribe-digitalsubscribe-printtwitter-square-holdtwitteryoutube